PDS Biotechnology (FRA:EU6) LT-Debt-to-Total-Asset: 0.43 (As of Mar. 2026)


FRA:EU6 PDS Biotechnology Corp FRA:EU6
32 GF Score
Price €0.75
! 1 Warning Sign
View Full Analysis

What is PDS Biotechnology LT-Debt-to-Total-Asset?

PDS Biotechnology FRA:EU6 +0.54% 32 LT-Debt-to-Total-Asset is 0.43 as of Mar. 2026. GuruFocus rates FRA:EU6 with a GF Score™ of 32/100. The stock has 1 warning sign investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. PDS Biotechnology's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.43.

PDS Biotechnology's long-term debt to total assets ratio increased from Mar. 2025 (0.14) to Mar. 2026 (0.43). It may suggest that PDS Biotechnology is progressively becoming more dependent on debt to grow their business.

PDS Biotechnology  (FRA:EU6) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

PDS Biotechnology LT-Debt-to-Total-Asset Related Terms

PDS Biotechnology LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for PDS Biotechnology's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PDS Biotechnology LT-Debt-to-Total-Asset Chart

PDS Biotechnology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.30 0.33 0.20 0.39

PDS Biotechnology Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.32 0.34 0.39 0.43
FRA:EU6
32GF Score
PDS Biotechnology Corp FRA:EU6
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PDS Biotechnology LT-Debt-to-Total-Asset Calculation

PDS Biotechnology's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )/Total Assets (A: Dec. 2025 )
=10.042/26.042
=

PDS Biotechnology's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )/Total Assets (Q: Mar. 2026 )
=9.19/21.333
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.43 mean?
PDS Biotechnology (FRA:EU6) has a LT-Debt-to-Total-Asset of 0.43 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on PDS Biotechnology and its competitors.
Is PDS Biotechnology's LT-Debt-to-Total-Asset too high?
PDS Biotechnology's current LT-Debt-to-Total-Asset is 0.43. Overall, PDS Biotechnology has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does PDS Biotechnology's LT-Debt-to-Total-Asset compare to LTRN and AURX?
PDS Biotechnology's LT-Debt-to-Total-Asset of 0.43 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Biotechnology company?
A good LT-Debt-to-Total-Asset depends on the Biotechnology industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on PDS Biotechnology and its competitors. PDS Biotechnology's current LT-Debt-to-Total-Asset is 0.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PDS Biotechnology stock overvalued right now?
PDS Biotechnology (FRA:EU6) has a current LT-Debt-to-Total-Asset of 0.43. The current LT-Debt-to-Total-Asset is 0.43. PDS Biotechnology's overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For PDS Biotechnology (FRA:EU6), the current LT-Debt-to-Total-Asset is 0.43 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PDS Biotechnology Business Description

Other Exchanges PDSB:USA
Address 303A College Road, East Princeton, NJ, USA, 08540
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.
32GF Score

Get the complete analysis for FRA:EU6

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.75
Price